ATE205202T1 - Imidazol-, triazol- und tetrazolderivate - Google Patents
Imidazol-, triazol- und tetrazolderivateInfo
- Publication number
- ATE205202T1 ATE205202T1 AT93905531T AT93905531T ATE205202T1 AT E205202 T1 ATE205202 T1 AT E205202T1 AT 93905531 T AT93905531 T AT 93905531T AT 93905531 T AT93905531 T AT 93905531T AT E205202 T1 ATE205202 T1 AT E205202T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- nitrogen
- represent
- date sep
- triazole
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title abstract 4
- 150000003536 tetrazoles Chemical class 0.000 title abstract 2
- 150000003852 triazoles Chemical class 0.000 title abstract 2
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 6
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 239000000556 agonist Substances 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Paints Or Removers (AREA)
- Lubricants (AREA)
- Epoxy Resins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929205482A GB9205482D0 (en) | 1992-03-13 | 1992-03-13 | Therapeutic agents |
| GB929215731A GB9215731D0 (en) | 1992-07-24 | 1992-07-24 | Therapeutic agents |
| PCT/GB1993/000474 WO1993018029A1 (en) | 1992-03-13 | 1993-03-05 | Imidazole, triazole and tetrazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE205202T1 true ATE205202T1 (de) | 2001-09-15 |
Family
ID=26300519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93905531T ATE205202T1 (de) | 1992-03-13 | 1993-03-05 | Imidazol-, triazol- und tetrazolderivate |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5510362A (de) |
| EP (1) | EP0630374B1 (de) |
| JP (1) | JP3309982B2 (de) |
| AT (1) | ATE205202T1 (de) |
| AU (1) | AU669160B2 (de) |
| CA (1) | CA2129146A1 (de) |
| DE (1) | DE69330713T2 (de) |
| WO (1) | WO1993018029A1 (de) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9402016D0 (en) * | 1994-02-02 | 1994-03-30 | Merck Sharp & Dohme | Therapeutic agents |
| GB9410031D0 (en) * | 1994-05-19 | 1994-07-06 | Merck Sharp & Dohme | Therapeutic agents |
| US5552402A (en) * | 1994-05-19 | 1996-09-03 | Merck, Sharp & Dohme Ltd. | Five-membered heteroaromatic compounds as 5-HT receptor agonists |
| EP0759918A1 (de) * | 1994-05-19 | 1997-03-05 | MERCK SHARP & DOHME LTD. | Indol-3-ylalkyl-piperidin-piperazin, -piperidin und tetrahydropyridin-derivate als 5-ht1 d-alpha agonisten |
| EP0804434A1 (de) * | 1994-08-02 | 1997-11-05 | MERCK SHARP & DOHME LTD. | Azetidin, pyrrolidin-und piperidinderivate |
| GB9423460D0 (en) * | 1994-11-21 | 1995-01-11 | Merck Sharp & Dohme | Therapeutic agents |
| GB9501865D0 (en) * | 1995-01-31 | 1995-03-22 | Merck Sharp & Dohme | Therapeutic agents |
| US5770742A (en) * | 1996-05-16 | 1998-06-23 | Allelix Biopharmaceuticals Inc. | Thiophene-tryptamine derivatives |
| EP1594847A2 (de) * | 2003-02-12 | 2005-11-16 | Transtech Pharma, Inc. | Substituierte azolderivate zur therapeutischen verwendung |
| JP4898458B2 (ja) * | 2004-02-12 | 2012-03-14 | トランス テック ファーマ，インコーポレイテッド | 置換アゾール誘導体、組成物及び使用方法 |
| JP4954083B2 (ja) * | 2004-11-18 | 2012-06-13 | シンタ ファーマスーティカルズ コーポレイション | Ｈｓｐ９０活性を調節するトリアゾール化合物 |
| TWI446910B (zh) * | 2005-08-18 | 2014-08-01 | Synta Pharmaceuticals Corp | 調節ｈｓｐ９０活性的三唑化合物 |
| ZA200805648B (en) | 2006-01-30 | 2009-09-30 | Transtech Pharma Inc | Substituted imidazole derivatives and their use as PTPase inhibitors |
| US8183384B2 (en) | 2006-05-25 | 2012-05-22 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate HSP90 activity |
| EP2034996A2 (de) * | 2006-05-25 | 2009-03-18 | Synta Pharmaceuticals Corporation | Hsp90-aktivität modulierende triazolverbindungen |
| PT2035396E (pt) * | 2006-05-25 | 2014-07-29 | Synta Pharmaceuticals Corp | Compostos de triazol que modulam a atividade da hsp90 |
| AU2007267852A1 (en) * | 2006-05-25 | 2007-12-06 | Synta Pharmaceuticals Corp. | Compounds that modulate Hsp90 activity and methods for identifying same |
| WO2009102761A1 (en) * | 2008-02-12 | 2009-08-20 | Bristol-Myers Squibb Company | 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| EP2560640A1 (de) | 2010-04-19 | 2013-02-27 | Synta Pharmaceuticals Corp. | Krebstherapie mit einer kombination aus hsp90-inhibitorverbindungen und einem egfr-hemmer |
| AU2012332421A1 (en) | 2011-11-02 | 2014-06-05 | Synta Pharmaceuticals Corp. | Cancer therapy using a combination of Hsp90 inhibitors with topoisomerase I inhibitors |
| AU2012332424A1 (en) | 2011-11-02 | 2014-06-05 | Synta Pharmaceuticals Corp. | Combination therapy of Hsp90 inhibitors with platinum-containing agents |
| WO2013074594A1 (en) | 2011-11-14 | 2013-05-23 | Synta Pharmaceuticals Corp. | Combination therapy of hsp90 inhibitors with braf inhibitors |
| HUE050317T2 (hu) | 2015-05-20 | 2020-11-30 | Amgen Inc | APJ receptor triazol agonistái |
| EP3452466B1 (de) | 2016-05-03 | 2020-08-12 | Amgen Inc. | Heterocyclische triazolverbindungen als agonisten des apj-rezeptors |
| EP3541803B1 (de) | 2016-11-16 | 2020-12-23 | Amgen Inc. | Triazolpyridylverbindungen als agonisten des apj-rezeptors |
| WO2018097944A1 (en) | 2016-11-16 | 2018-05-31 | Amgen Inc. | Triazole furan compounds as agonists of the apj receptor |
| US10906890B2 (en) | 2016-11-16 | 2021-02-02 | Amgen Inc. | Triazole phenyl compounds as agonists of the APJ receptor |
| MA46824A (fr) | 2016-11-16 | 2019-09-25 | Amgen Inc | Composés de triazole substitués par alkyle en tant qu'agonistes du récepteur apj |
| US11046680B1 (en) | 2016-11-16 | 2021-06-29 | Amgen Inc. | Heteroaryl-substituted triazoles as APJ receptor agonists |
| US11020395B2 (en) | 2016-11-16 | 2021-06-01 | Amgen Inc. | Cycloalkyl substituted triazole compounds as agonists of the APJ receptor |
| JP7189155B2 (ja) | 2017-05-17 | 2022-12-13 | アーカス バイオサイエンシズ インコーポレイティド | 癌関連障害の治療のためのキナゾリン－ピラゾール誘導体 |
| EP3704122B1 (de) | 2017-11-03 | 2021-09-01 | Amgen Inc. | Fusionierte triazolagonisten des apj-rezeptors |
| MA52487A (fr) | 2018-05-01 | 2021-03-10 | Amgen Inc | Pyrimidinones substituées en tant qu'agonistes du récepteur apj |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
| CZ288351B6 (en) * | 1990-06-07 | 2001-05-16 | Astrazeneca Ab | Nitrogenous heterocyclic compound, process of its preparation and use as well as a medicament containing thereof |
| SK278998B6 (sk) * | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu, spôsob i |
-
1993
- 1993-03-05 EP EP93905531A patent/EP0630374B1/de not_active Expired - Lifetime
- 1993-03-05 DE DE69330713T patent/DE69330713T2/de not_active Expired - Fee Related
- 1993-03-05 JP JP51546793A patent/JP3309982B2/ja not_active Expired - Fee Related
- 1993-03-05 AT AT93905531T patent/ATE205202T1/de not_active IP Right Cessation
- 1993-03-05 US US08/295,884 patent/US5510362A/en not_active Expired - Fee Related
- 1993-03-05 CA CA002129146A patent/CA2129146A1/en not_active Abandoned
- 1993-03-05 AU AU36428/93A patent/AU669160B2/en not_active Ceased
- 1993-03-05 WO PCT/GB1993/000474 patent/WO1993018029A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP3309982B2 (ja) | 2002-07-29 |
| US5510362A (en) | 1996-04-23 |
| CA2129146A1 (en) | 1993-09-16 |
| WO1993018029A1 (en) | 1993-09-16 |
| EP0630374A1 (de) | 1994-12-28 |
| DE69330713D1 (de) | 2001-10-11 |
| EP0630374B1 (de) | 2001-09-05 |
| DE69330713T2 (de) | 2002-07-04 |
| AU669160B2 (en) | 1996-05-30 |
| JPH07504431A (ja) | 1995-05-18 |
| AU3642893A (en) | 1993-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE205202T1 (de) | Imidazol-, triazol- und tetrazolderivate | |
| CA2238140A1 (en) | Imidazole, triazole and tetrazole derivatives | |
| DE69324140D1 (de) | Kondensierte imidazol- und triazolderivate als 5-hta rezeptoragonisten | |
| HUP0000739A2 (hu) | Alkánszulfonil-amino-csoportot tartalmazó alkán- és heterociklusos karbonsavszármazékok, az ezeket tartalmazó gyógyszerkészítmények, valamint csontritkulás kezelésére szolgáló kombinált gyógyszerkészítmények | |
| HU9300618D0 (en) | Imidazole derivatives containing biphenyl-sulfonyl-urea side chain or biphenyl-sulfonyl-urethane one as well as method for producing them and their utilization | |
| NZ333302A (en) | Substituted 6,5-hetero-bicyclic derivatives for the prevention or inhibition of a disorder that can be treated by antagonising corticotropin releasing factor | |
| PL311204A1 (en) | Indole derivatives as antagonists of 5-ht-like receptors for use in hemicrania | |
| YU173791A (sh) | Indol i benzimidazol-supstituisani imidazol i benzimidazol derivati | |
| MX9709451A (es) | Derivados de benzisoxazol e indazol como agentes antipsicoticos. | |
| ES2115053T3 (es) | Derivados indolicos inhibidores de la 5alfa-reductasa de esteroides. | |
| ATE197453T1 (de) | Imidazol-, triazol- und tetrazolderivate | |
| SE9201076L (sv) | Användningen av gamla läkemedel för behandling av diabetes | |
| ATE255102T1 (de) | Benzothiophenderivate, ihre herstellung und verwendung als urokinase-inhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |